327 related articles for article (PubMed ID: 34680057)
1. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
Wu SB; Hou TY; Kau HC; Tsai CC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
[TBL] [Abstract][Full Text] [Related]
2. JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves' Orbital Fibroblasts.
Hou TY; Wu SB; Kau HC; Tsai CC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799469
[TBL] [Abstract][Full Text] [Related]
3. Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.
Tsai CC; Wu SB; Kau HC; Wei YH
Sci Rep; 2018 May; 8(1):7276. PubMed ID: 29739987
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Suppresses TGF-β1-Induced Myofibroblast Differentiation and Attenuates Angiogenic Activity of Orbital Fibroblasts.
Yu WK; Hwang WL; Wang YC; Tsai CC; Wei YH
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202024
[TBL] [Abstract][Full Text] [Related]
5. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
6. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts
Wei YH; Liao SL; Wang SH; Wang CC; Yang CH
Front Endocrinol (Lausanne); 2020; 11():607968. PubMed ID: 33597925
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
Choi K; Lee K; Ryu SW; Im M; Kook KH; Choi C
Mol Vis; 2012; 18():1010-20. PubMed ID: 22550395
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
10. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
Conte E; Gili E; Fagone E; Fruciano M; Iemmolo M; Vancheri C
Eur J Pharm Sci; 2014 Jul; 58():13-9. PubMed ID: 24613900
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
12. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
Shin JM; Park JH; Park IH; Lee HM
Am J Rhinol Allergy; 2015; 29(6):408-13. PubMed ID: 26637578
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
Tong BD; Xiao MY; Zeng JX; Xiong W
Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
[TBL] [Abstract][Full Text] [Related]
15. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
16. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts.
Szóstek-Mioduchowska AZ; Lukasik K; Skarzynski DJ; Okuda K
Theriogenology; 2019 Jan; 124():9-17. PubMed ID: 30321755
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy.
Yoon JS; Chae MK; Jang SY; Lee SY; Lee EJ
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5921-9. PubMed ID: 22871832
[TBL] [Abstract][Full Text] [Related]
18. Response of fibroblasts to transforming growth factor-β1 on two-dimensional and in three-dimensional hyaluronan hydrogels.
Chen X; Thibeault SL
Tissue Eng Part A; 2012 Dec; 18(23-24):2528-38. PubMed ID: 22734649
[TBL] [Abstract][Full Text] [Related]
19. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
